GoodRx (GDRX)
(Real Time Quote from BATS)
$7.05 USD
-0.03 (-0.42%)
Updated Sep 20, 2024 10:18 AM ET
3-Hold of 5 3
D Value D Growth F Momentum F VGM
Balance Sheet
Fiscal Year End for GoodRx Holdings, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 672 | 757 | 941 | 972 | 26 |
Receivables | 144 | 117 | 118 | 69 | 48 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Other Current Assets | 57 | 45 | 30 | 46 | 12 |
Total Current Assets | 873 | 920 | 1,089 | 1,086 | 87 |
Net Property & Equipment | 111 | 90 | 67 | 43 | 7 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 65 | 0 | 0 | 13 | 2 |
Intangibles | 472 | 532 | 418 | 298 | 257 |
Deposits & Other Assets | 38 | 27 | 6 | 2 | 1 |
Total Assets | 1,589 | 1,605 | 1,608 | 1,470 | 387 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 36 | 18 | 18 | 10 | 8 |
Current Portion Long-Term Debt | 9 | 7 | 7 | 7 | 7 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 71 | 48 | 51 | 38 | 16 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 123 | 76 | 81 | 60 | 33 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 648 | 652 | 656 | 660 | 664 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 8 | 8 | 5 | 6 | 3 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 827 | 790 | 776 | 759 | 737 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 737 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 2,219 | 2,263 | 2,247 | 2,102 | 9 |
Retained Earnings | -1,457 | -1,449 | -1,416 | -1,390 | -1,097 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 762 | 815 | 832 | 711 | -351 |
Total Liabilities & Shareholder's Equity | 1,589 | 1,605 | 1,608 | 1,470 | 387 |
Total Common Equity | 762 | 815 | 832 | 711 | -1,088 |
Shares Outstanding | 394.00 | 397.00 | 400.50 | 391.60 | NA |
Book Value Per Share | 1.93 | 2.05 | 2.08 | 1.82 | 0.01 |
Fiscal Year End for GoodRx Holdings, Inc falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 525 | 533 | 672 | 795 | 762 |
Receivables | 162 | 145 | 144 | 121 | 123 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Other Current Assets | 64 | 55 | 57 | 53 | 34 |
Total Current Assets | 751 | 733 | 873 | 969 | 919 |
Net Property & Equipment | 126 | 119 | 111 | 109 | 111 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 65 | 65 | 65 | 58 | 63 |
Intangibles | 467 | 469 | 472 | 502 | 521 |
Deposits & Other Assets | 37 | 37 | 38 | 39 | 44 |
Total Assets | 1,475 | 1,454 | 1,589 | 1,708 | 1,692 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 17 | 34 | 36 | 33 | 7 |
Current Portion Long-Term Debt | 7 | 7 | 9 | 7 | 7 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 73 | 71 | 71 | 75 | 66 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 102 | 117 | 123 | 118 | 83 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 646 | 647 | 648 | 649 | 650 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 9 | 8 | 8 | 10 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 806 | 823 | 827 | 827 | 797 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 2,121 | 2,089 | 2,219 | 2,313 | 2,288 |
Retained Earnings | -1,452 | -1,458 | -1,457 | -1,432 | -1,393 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 669 | 631 | 762 | 881 | 895 |
Total Liabilities & Shareholder's Equity | 1,475 | 1,454 | 1,589 | 1,708 | 1,692 |
Total Common Equity | 669 | 631 | 762 | 881 | 895 |
Shares Outstanding | 379.40 | 395.00 | 394.00 | 398.30 | 396.60 |
Book Value Per Share | 1.76 | 1.60 | 1.93 | 2.21 | 2.26 |